Integrated community-directed intervention for schistosomiasis and soil transmitted helminths in western Kenya - A pilot study

Parasites and Vectors

Volumn 5, Issue 1, 2012, Pages

  Mwinzi, Pauline N M ^a   Montgomery, Susan P ^c   Owaga, Chrispin O ^a   Mwanje, Mariam ^b   Muok, Erick M ^a   Ayisi, John G ^a   Laserson, Kayla F ^c   Muchiri, Erick M ^b   Secor, W Evan ^c   Karanja, Diana M S ^a  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b Ministry of Public Health and Sanitation   (Kenya)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; PRAZIQUANTEL;

ABDOMINAL PAIN; ADULT; ARTICLE; ASCARIS LUMBRICOIDES; CHILD; COMMUNITY; DIARRHEA; ENDEMIC DISEASE; FATIGUE; FEASIBILITY STUDY; FEMALE; HOOKWORM; HOUSEHOLD; HUMAN; INFECTION CONTROL; KENYA; MALE; NONHUMAN; PILOT STUDY; PREVALENCE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SOIL; TRICHURIS TRICHIURA; VOMITING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; FEASIBILITY STUDIES; FEMALE; HELMINTHIASIS; HOOKWORM INFECTIONS; HUMANS; KENYA; MALE; MIDDLE AGED; PILOT PROJECTS; PRAZIQUANTEL; PREVALENCE; SCHISTOSOMIASIS; SOCIOECONOMIC FACTORS; SOIL; TRICHURIASIS;

ANCYLOSTOMATOIDEA; SCHISTOSOMA; TRICHURIS; VERMES;

EID: 84865541442     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-5-182     Document Type: Article

References (33)

1. The global status of schistosomiasis and its control. Chitsulo L, Engels D, Montresor A, Savioli L, Acta Trop 2000 77 1 41 51 10.1016/S0001-706X(00) 00122-4 10996119
2. The impact of schistosomiasis on human nutrition. Stephenson L, Parasitology 1993 107 Suppl 107 123 8115176
3. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. King CH, Dickman K, Tisch DJ, Lancet 2005 365 9470 1561 1569 10.1016/S0140-6736(05)66457-4 15866310 (Pubitemid 40615405)
4. Schistosoma mansoni shares a protective carbohydrate epitope with keyhole limpet hemocyanin. Grzych JM, Dissous C, Capron M, Torres S, Lambert PH, Capron A, J Exp Med 1987 165 3 865 878 10.1084/jem.165.3.865 2434601 (Pubitemid 17059458)
5. Studies on schistosomiasis in western Kenya: I Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Karanja DM, Colley DG, Nahlen BL, Ouma JH, Secor WE, Am J Trop Med Hyg 1997 56 5 515 521 9180601 (Pubitemid 27230073)
6. Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1. Karanja DM, Boyer AE, Strand M, Colley DG, Nahlen BL, Ouma JH, Secor WE, Am J Trop Med Hyg 1998 59 2 307 311 9715952 (Pubitemid 28418994)
7. Morbidity in schistosomiasis: an update. Ouma JH, Vennervald BJ, Butterworth AE, Trends Parasitol 2001 17 3 117 118 10.1016/S1471-4922(00)01877-8 11345060 (Pubitemid 32422173)
8. Short report: Evaluation of hepatic fibrosis in persons co-infected with Schistosoma mansoni and human immunodeficiency virus 1. Mwinzi PN, Karanja DM, Kareko I, Magak PW, Orago AS, Colley DG, Secor WE, Am J Trop Med Hyg 2004 71 6 783 786 15642972 (Pubitemid 40075631)
9. Geographic distribution of schistosomiasis and soil-transmitted helminths in Western Kenya: implications for anthelminthic mass treatment. Handzel T, Karanja DM, Addiss DG, Hightower AW, Rosen DH, Colley DG, Andove J, Slutsker L, Secor WE, Am J Trop Med Hyg 2003 69 3 318 323 14628951
10. Performance of circulating cathodic antigen (CCA) urine-dipsticks for rapid detection of intestinal schistosomiasis in schoolchildren from shoreline communities of Lake Victoria. Standley C, Lwambo N, Lange C, Kariuki H, Adriko M, Stothard J, Parasit Vectors 3 1 7 10.1186/1756-3305-3-7
11. Integrated prevalence mapping of schistosomiasis, soil-transmitted helminthiasis and malaria in lakeside and island communities in Lake Victoria, Uganda. Kabatereine NB, Standley CJ, Sousa-Figueiredo JC, Fleming FM, Stothard JR, Talisuna A, Alan Fenwick A, Parasites & Vectors 2011 4 232 10.1186/1756-3305-4-232 22966139
12. Confirmed local endemicity and putative high transmission of Schistosoma mansoni in the Sesse Islands, Lake Victoria, Uganda. Standley CJ, Adriko M, Besigye F, Kabatereine NB, RJS, Parasites & Vectors 2011 4 29 10.1186/1756-3305-4-29 22966139
13. Epidemiology of single and multiple species of helminth infections among school children in Busia District, Kenya. Brooker S, Miguel EA, Moulin S, Luoba AI, Bundy DA, Kremer M, East Afr Med J 2000 77 3 157 161 12858892
14. Spatial co-distribution of neglected tropical diseases in the east African great lakes region: revisiting the justification for integrated control. Clements AC, Deville MA, Ndayishimiye O, Brooker S, Fenwick A, Trop Med Int Health 2010 15 2 198 207 10.1111/j.1365-3156.2009.02440.x 20409287
15. Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon. Wanji S, Tendogfor N, Nji T, Esum M, Che JN, Nkwescheu A, Alassa F, Kamnang G, Enyong PA, Taylor MJ, Hoerauf A, Taylor DW, Parasites and Vectors 2009 2 1 39 10.1186/1756-3305-2-39 19712455
16. Community-directed interventions for priority health problems in Africa: results of a multicountry study. CDI Study Group, Bulletin of the World Health Organization 2010 88 7 509 518 10.2471/BLT.09.069203 20616970
17. Community directed approach beyond ivermectin in Tanzania: a promising mechanism for the delivery of complex health interventions. Mutalemwa P, Kisinza WN, Kisoka WJ, Kilima S, Njau J, Tenu F, Nkya T, Magesa SM, Tanzanian Journal of Health Research 2009 11 116 125
18. Integrated community-directed treatment for the control of onchocerciasis, schistosomiasis and intestinal helminths infections in Uganda: advantages and disadvantages. Ndyomugyenyi R, Kabatereine N, Trop Med Int Health 2003 8 11 997 1004 10.1046/j.1360-2276.2003.01124.x 14629766 (Pubitemid 37386467)
19. APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations. African Programme for Onchocerciasis Control. Homeida M, Braide E, Elhassan E, Amazigo UV, Liese B, Benton B, Noma M, Etya'ale D, Dadzie KY, Kale OO, et al. Ann Trop Med Parasitol 2002 96 Suppl 1 93 104 12081254
20. A multi-centre study of community-directed ivermectin distributors' (CDDs') involvement in other healthcare and development programme activities in Cameroon, Togo, Sudan, Nigeria and Uganda. Sama MTH, Ngang P, Liese BH, Amazigo U, Seketeli A, Tropical Doctor 2003 33 4 237 241 14620432 (Pubitemid 37289903)
21. The achievements and challenges of the African Programme for Onchocerciasis Control (APOC). Seketeli A, Adeoye G, Eyamba A, Nnoruka E, Drameh P, Amazigo UV, Noma M, Agboton F, Aholou Y, Kale OO, et al. Ann Trop Med Parasitol 2002 96 Suppl 1 15 28 12630391
22. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters. Wamae CN, Njenga SM, Ngugi BM, Mbui J, Njaanake HK, Acta Tropica 2010 120 1 1 186
23. Impact of tworounds of mass treatment with diethylcarbamazine plus albendazole on Wuchereriabancrofti infection and the sensitivity of immunochromatographic test in Malindi, Kenya. Njenga SM, Wamae CN, Njomo DW, Mwandawiro CS, Molyneux DH, Transactoins Royal Society Tropical Medicine and Hygiene 2008 102 10 1017 1024 10.1016/j.trstmh.2008.04.039
24. Health and demographic surveillance in rural western Kenya: a platform for evaluating interventions to reduce morbidity and mortality from infectious diseases. Adazu K, Lindblade KA, Rosen DH, Odhiambo F, Ofware P, Kwach J, Van Eijk AM, Decock KM, Amornkul P, Karanja D, et al. Am J Trop Med Hyg 2005 73 6 1151 1158 16354829 (Pubitemid 43038271)
25. The challenges of community-directed treatment with ivermectin (CDTI) within the African Programme for Onchocerciasis Control (APOC). Amazigo UV, Brieger WR, Katabarwa M, Akogun O, Ntep M, Boatin B, N'Doyo J, Noma M, Seketeli A, Ann Trop Med Parasitol 2002 96 Suppl 1 41 58 12625916
26. Alternatives to bodyweight for estimating the dose of praziquantel needed to treat schistosomiasis. Hall A, Nokes C, Wen ST, Adjei S, Kihamia C, Mwanri L, Bobrow E, de Graft-Johnson J, Bundy D, Trans R Soc Trop Med Hyg 1999 93 6 653 658 10.1016/S0035-9203(99)90087-1 10717759 (Pubitemid 30015798)
27. Development and validation of a 'tablet pole' for the administration of praziquantel in sub-Saharan Africa. Montresor A, Engels D, Chitsulo L, Bundy DA, Brooker S, Savioli L, Trans R Soc Trop Med Hyg 2001 95 5 542 544 10.1016/S0035-9203(01)90034-3 11706670 (Pubitemid 34947414)
28. Using ivermectin-treatment coverage among schoolchildren monitored by schoolteachers as a proxy of population coverage in areas of Uganda where onchocerciasis is endemic. Ndyomugyenyi R, Remme J, Ann Trop Med Parasitol 2002 96 1 53 60 10.1179/000349802125000510 11989535 (Pubitemid 34407197)
29. Malaria control: constraints and opportunities. Kager PA, Trop Med Int Health 2002 7 12 1042 1046 10.1046/j.1365-3156.2002.00981.x 12460395 (Pubitemid 36960252)
30. The contribution of health-care services to a sound and sustainable malaria-control policy. Moerman F, Lengeler C, Chimumbwa J, Talisuna A, Erhart A, Coosemans M, D'Alessandro U, Lancet Infect Dis 2003 3 2 99 102 10.1016/S1473-3099(03)00518-8 12560195 (Pubitemid 36164206)
31. Reversing the trend of weak policy implementation in the Kenyan health sector?-a study of budget allocation and spending of health resources versus set priorities. Glenngard AH, Maina TM, Health Res Policy Syst 2007 5 3 10.1186/1478-4505-5-3 17394640 (Pubitemid 46585639)
32. APOC report, 2006 http://www.who.int/tdr/publications/publications/pdf/ cdti.pdf (Accessed January 2010)
33. Supporting the delivery of cost-effective interventions in primary health-care systems in low-income and middle-income countries: an overview of systematic reviews. Lewin S, Lavis JN, Oxman AD, Bastías G, Chopra M, Ciapponi A, Flottorp S, Martí SG, Pantoja T, Rada G, et al. Lancet 2008 372 9642 928 939 10.1016/S0140-6736(08)61403-8 18790316